Medpace Holdings (MEDP) Capital Expenditures (2015 - 2026)

Medpace Holdings has reported Capital Expenditures for 12 years, with the latest figure at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 31.82% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $28.2 million (down 31.35% YoY), and the FY2025 full-year result was $31.4 million, down 14.21% from the prior year.
• Capital Expenditures for Q1 2026 stood at $6.8 million, up from $4.5 million in the prior quarter.
• The five-year high for Capital Expenditures was $12.9 million in Q2 2024, with the low at $4.5 million in Q4 2025.
• Historically, Capital Expenditures has averaged $8.7 million across 5 years, with a median of $9.2 million in 2022.
• Annual changes were most pronounced in 2022 — Capital Expenditures jumped 86.42% — and 2025, when it sank 52.51%.
• Medpace Holdings' Capital Expenditures stood at $9.2 million in 2022, then rose by 8.04% to $10.0 million in 2023, then slipped by 23.46% to $7.6 million in 2024, then slumped by 40.65% to $4.5 million in 2025, then jumped by 50.22% to $6.8 million in 2026.
• The last three Capital Expenditures figures came in at $6.8 million (Q1 2026), $4.5 million (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.